Skip to main content

Peer Review reports

From: Hyperlactatemia is a predictor of mortality in patients undergoing continuous renal replacement therapy for acute kidney injury

Original Submission
5 Oct 2022 Submitted Original manuscript
25 Oct 2022 Reviewed Reviewer Report - Yan Huo
31 Oct 2022 Reviewed Reviewer Report - Buyun Wu
21 Nov 2022 Reviewed Reviewer Report
6 Dec 2022 Author responded Author comments - Seung Seok Han
Resubmission - Version 2
6 Dec 2022 Submitted Manuscript version 2
10 Dec 2022 Reviewed Reviewer Report - Buyun Wu
12 Dec 2022 Reviewed Reviewer Report
31 Dec 2022 Reviewed Reviewer Report - Yan Huo
4 Jan 2023 Author responded Author comments - Seung Seok Han
Resubmission - Version 3
4 Jan 2023 Submitted Manuscript version 3
Publishing
12 Jan 2023 Editorially accepted
14 Jan 2023 Article published 10.1186/s12882-023-03063-y

You can find further information about peer review here.

Back to article page